Ambria Capital

Ambria Capital is a private equity firm dedicated to empowering early-stage companies in the healthcare and technology sectors. The firm focuses on investing in entrepreneurs committed to transforming markets and improving lives. Their investment areas include psychedelics, digital health, cryptocurrency, and cybersecurity. Ambria Capital emphasizes a hands-on approach, investing their own capital and making independent decisions to support their portfolio companies over the long term. They are particularly interested in companies that are solving pressing issues of the current generation, reflecting their belief in the potential of innovative solutions to create meaningful impact. The firm has invested in over 20 companies, including atai and Small Pharma, and is known for its comprehensive analytical approach and extensive network of industry contacts. Ambria Capital's mission is to support entrepreneurs who are committed to transforming markets and improving millions of lives, with a particular focus on sectors such as psychedelics, digital health, cryptocurrency, and cybersecurity. Their investment strategy combines a comprehensive analytical approach with an unparalleled network of contacts, connecting industry leaders with market opportunities. The firm is headquartered in San Juan, Puerto Rico, and was founded in 2019 by Michael Sobeck, who also serves as the founder of the Perception Restoration Foundation, a non-profit dedicated to the treatment of HPPD. Ambria Capital's portfolio includes investments in companies like atai and Small Pharma, reflecting their commitment to supporting innovative solutions in the healthcare and technology sectors. The firm's investment philosophy centers on empowering entrepreneurs who are dedicated to making a positive impact and driving market transformation, with a particular emphasis on addressing significant challenges in mental health and technology through innovative approaches.